Phase I Testing Begins on Second Compound Developed from AMRI (AMRI), Bristol-Myers (BMY) Collaboration; AMRI to Receive $4M Milestone Payment
Tweet Send to a Friend
AMRI (NASDAQ: AMRI) announced today that Bristol-Myers Squibb Company (NYSE: BMY) has submitted a Clinical Trial Application to the Medical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
